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Abstract
In the mammary gland Bcl-x is the most abundant cell survival factor from the Bcl-2 family. Since Bcl-x null mice die around day 12 of
embryogenesis, the relevance of this protein in organ development and function is poorly understood. In erythroid cells bcl-x gene expression
is controlled by cytokines and the transcription factor Stat5 (signal transducer and activator of transcription). However, we identified that bcl-
x RNA levels in mammary tissue from prolactin receptor- and Stat5-null mice were indistinguishable from wild type mice. We have proposed
that Bcl-x might control the survival of mammary epithelial cells throughout pregnancy, lactation, and the early stages of involution, and we
have now tested this hypothesis through the conditional deletion of the bcl-x gene from mouse mammary epithelium. Conditional (floxed)
bcl-x alleles were excised from alveolar cells during pregnancy using a Cre transgene under the control of the whey acidic protein gene
promoter. Deletion of the bcl-x gene from the entire epithelial compartment (ducts and alveoli) was achieved by expressing Cre-recombinase
under control of the mouse mammary tumor virus long terminal repeat. The absence of Bcl-x did not compromise proliferation and
differentiation of mammary ductal and alveolar epithelial cells in virgin mice and during pregnancy and lactation. However, epithelial
cell death and tissue remodeling were accelerated in the bcl-x conditional knockout mice during the first stage of involution. Concomitant
deletion of the bax gene did not significantly modify the Bcl-x phenotype. Our results suggest that Bcl-x is not essential during mammopoi-
esis, but is critical for controlled apoptosis during the first phase of involution. Published by Elsevier Science Ireland Ltd.
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1. Introduction
The developmental cycle of mammary tissue encom-
passes the proliferation of alveolar epithelium during preg-
nancy, its functional differentiation at parturition, and a
lactational period followed by death and remodeling of
the epithelium during involution (for review see Hennigh-
ausen and Robinson, 1998). Involution of mouse mammary
tissue occurs in two distinct phases, a reversible and a non-
reversible phase (Li et al., 1997; Lund et al., 1996). While
apoptotic cell death is characteristic for both phases, the
irreversible phase is also characterized by protease-
mediated remodeling of mammary epithelium (Lund et
al., 1996). Upon weaning, the levels of lactogenic hormones
decrease sharply, which results in the downregulation of the
prolactin/Stat5 pathway (Liu et al., 1996) and a concomitant
reduction in milk protein gene expression (Burdon et al.,
1991). Apoptosis can be observed within 24–48 h, which
is followed by tissue remodeling.
As demonstrated in nipple sealing experiments (Li et al.,
1997), and in oxytocin deficient mice that lack the milk ejec-
tion reflex (Wagner et al., 1997b), epithelial cell death in
mammary tissue is triggered, in part, by local stimuli and
not by declining levels of prolactin. Experimental mouse
genetics has demonstrated that apoptosis and involution are
independent of p53 (Li et al., 1996). The precise control of
involution is possibly achieved through a shift in the balance
of molecules that mediate cell survival and cell death. While
the activity of the transcription factor Stat5 is lost within 24 h
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of involution, Stat3 activity is induced (Liu et al., 1996).
Deletion of the Stat3 gene specifically from mammary
epithelium during pregnancy demonstrated that Stat3 is
partly responsible for cell death in mammary epithelium
(Chapman et al., 1999). It has been proposed that the Bcl-2
family of cell survival and death proteins controls the initial
phase of involution. There are more than 15 members of the
Bcl-2 family that are divided into two groups, pro-apoptotic
and pro-survival. The pro-survival factors include Bcl-2,
Bcl-w, and Bcl-xL, and the pro-apoptotic factors include
Bax, Bad, Bcl-xS, and Bak (Adams and Cory, 2001). Bcl-x
and Bax are the two most prominent Bcl-2 family members
expressed in mammary tissue (Heermeier et al., 1996). In
tissue culture cells, transfected Bcl-x was shown to convey
resistance to apoptosis induced by cytokine deprivation
(Boise et al., 1993). Bax expression has been shown to be
elevated in some tissues after apoptotic stimuli and to
promote death when overexpressed in tissue culture cells
(Heermeier et al., 1996; Oltvai et al., 1993). Bcl-x mRNA
levels are low in virgin mammary tissue, but increase during
pregnancy in parallel with Stat5 activation and cell differen-
tiation. Stat5 can activate bcl-x gene transcription in
erythroid cells (Socolovsky et al., 1999), but this pathway
has not been investigated in mammary cells. Bcl-x mRNA
levels decrease during lactation, but increase again sharply
within 48 h of involution (Heermeier et al., 1996). Similarly,
Bax levels increase with the onset of involution (Heermeier
et al., 1996). Two isoforms of Bcl-x have been described. The
long form (Bcl-xL), consisting of 233 amino acids, is more
abundant and promotes cell survival. The short form (Bcl-xS)
has been identified as a reverse transcriptase polymerase
chain reaction (RT-PCR) product, which consists of 170
amino acids and induces cell death upon overexpression in
tissue culture cells (Boise et al., 1993). However, its presence
and relevance in vivo are unclear.
The abundance of Bcl-x in mammary epithelial cells and
its developmental regulation suggest that it could serve two
functions. First, it may promote the survival of mammary
epithelial cells during pregnancy. Second, Bcl-x may
provide survival cues at the transition of lactation and invo-
lution and thus balance the death-inducing function of Bax
to bring about a controlled remodeling of the gland. Experi-
mental mouse genetics has provided information on the
roles of Bcl-2 (Murphy et al., 1999; Schorr et al., 1999),
Bcl-w (Metcalfe et al., 1999; Print et al., 1998), and Bax
(Brady and Gil-Gomez, 1998; Knudson et al., 1995; Naka et
al., 1998; Schorr et al., 1999; Shindler et al., 1997) in orga-
nogenesis. No adverse effects on mammary development
have been reported in these mice. A genetic evaluation of
the role of Bcl-x in mammary gland development has not
been feasible since Bcl-x null mice die at around day 12.5 of
embryonic development (Motoyama et al., 1995).
Three main objectives have been addressed. First, we
defined the role of Bcl-x in mammary gland development.
Second, we examined the possibility that the prolactin/Stat5
pathway may control bcl-x gene transcription in the
mammary epithelium. Third, we investigated the proposed
balance of anti-apoptotic Bcl-x and pro-apoptotic Bax in the
mammary gland. We studied the role of Bcl-x through the
deletion of the gene specifically in mammary epithelium
using a Cre-loxP recombination approach. We have gener-
ated mice that carry loxP sites in the bcl-x gene promoter
region and the second intron (Rucker et al., 2000), and
transgenic mice that express Cre-recombinase in mammary
epithelium under control of the whey acidic protein (WAP)
gene promoter and the MMTV-LTR (Wagner et al., 1997a).
Through the generation of mice that carry two targeted bcl-x
alleles and a Cre transgene, we were able to genetically
define the roles of Bcl-x in mammary gland development
and function. We also deleted the bax gene from these mice
and investigated the possible balancing effect of Bcl-x and
Bax. Finally, using PrlR- and Stat5-null mice, we tested
whether prolactin and Stat5 regulate bcl-x gene expression.
2. Results
2.1. Expression of the bcl-x gene throughout mammary
development
Although the profile of Bcl-x during mammary develop-
ment has been published (Heermeier et al., 1996), a quanti-
tative analysis of bcl-x RNA in direct comparison to other
family members has not been reported. We analyzed bcl-w,
bfl-1, bcl-x, bak, bax, bcl-2.and bad RNA levels using a
quantitative RNase protection assay (Fig. 1A). RNA
(7 mg) from the different stages of mammary development
were analyzed and L32 and GAPDH transcripts were used as
loading controls. Bcl-x, bak, and bax transcripts were
expressed most highly at all stages of development, but
their respective levels did not change dramatically between
day 10 of pregnancy and lactation (Fig. 1A, lanes 3–5).
However, their expression increased sharply within the
first 24 h after weaning (Fig. 1A, lanes 7–9), and subse-
quently declined around days 3–4 (Fig. 1A, lanes 10, 11).
In particular, while bcl-x and bax RNA levels were compar-
able 24 h after weaning, the ratio shifted towards bax by day
4 of involution (compare Fig. 1A, lanes 9 and 11). The
levels of bfl-1 transcripts were low throughout development,
but increased sharply at 4 days post-weaning (Fig. 1A, lane
11). Since remodeling of the epithelium is in full progress
by day 4 of involution and lymphocytes have invaded the
mammary gland, it is possible that the increased expression
results from the presence of these cells. In contrast, the
elevated levels of bcl-x and bax RNA are the result of
increased gene expression in the epithelium as previously
demonstrated by in situ hybridization (Heermeier et al.,
1996). The level of bcl-w transcripts remained stable
throughout development. Bcl-2 transcripts were not
detected at any developmental stage. The reason for the
rather low expression levels of Bcl-2 family members (but
not L32 and GAPDH) at 6 h after weaning is not clear.
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2.2. Expression of the bcl-x gene in mammary epithelium is
not under control of the prolactin receptor or Stat5
In erythroid cells bcl-x gene activity is induced by the
transcription factor Stat5 (Kieslinger et al., 2000; Soco-
lovsky et al., 1999). Since Stat5 conveys cell survival
signals in both erythroid (Socolovsky et al., 1999) and
mammary alveolar cells (Humphreys and Hennighausen,
1999), we asked whether Stat5 also controls bcl-x gene
expression in mammary epithelium. RNA was isolated
from mammary tissue of wild type (Fig. 1A,B) and
Stat5a-null (Fig. 1B) mice at different stages of develop-
ment. Analysis of the Bcl-2 family members was performed
using RNase protection assays as discussed above. The
expression pattern of all genes, including bcl-x, was similar
in wild type and Stat5a-null mice (Fig. 1B).
Since PrlR- and Stat5-null (lack Stat5a and 5b) mice are
infertile we could not evaluate directly Bcl-x levels after a
full pregnancy. We therefore transplanted wild type, PrlR-
and Stat5-null epithelium into cleared fat pads of wild type
mice, and analyzed mammary protein at parturition (lacta-
tion day 1) after one pregnancy (Fig. 2). Bcl-x levels in the
PrlR- and Stat5-null tissues were even higher than in wild
type tissue. Expression of Stat1 and Stat3 was similar in
PrlR-null, Stat5-null, and wild type littermates. The weak
Stat5a and 5b signals in the Stat5-null transplants were
derived from the stroma of the wild type hosts. Bcl-x,
Stats 1 and 5 and SGP-2 were found in wild type stroma.
From these experiments we conclude that bcl-x gene tran-
scription in mammary tissue, unlike in the erythroid system,
is not controlled by Stat5.
2.3. Targeted deletion of the bcl-x gene from mammary
epithelium
Based on our expression studies and in situ hybridization
experiments (Heermeier et al., 1996), we hypothesized that
Bcl-x could mediate cell survival during pregnancy and the
first phase of involution. To test this hypothesis in the
mouse, we deleted the bcl-x gene specifically from
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Fig. 1. RNase protection assays of mammary gland RNA with bcl-2 family member probes (bcl-w, bfl-1, bcl-x, bak, bax, and bad) and analysis of bcl-x RNA
from PRLR knockout and Stat5a/5b double knockout mice. (A) Various developmental stages of wild type (C57BL/6) mammary tissue (7 mg of RNA were
analyzed for each time point). Lanes 1–12 in order are: kit control (1), virgin (2), pregnancy day 10 (3), pregnancy day 13 (4), lactation day 10 (5), involution
6 h (6), involution 12 h (7), involution 18 h (8), involution 24 h (9), involution 3 days (10), involution 4 days (11), and molecular weight marker (12). The band
observed between bad and L32 may be the result of non-specific nicks. (B) Various developmental stages of mammary tissue from Stat5a-null (lanes 1–6) and
wild type (lanes 7–12) mice. Lanes 1 and 7, virgin; lanes 2 and 8, pregnancy day 9; lanes 3 and 9, pregnancy day 13; lanes 4 and 10, pregnancy day 16; lanes 5
and 11, pregnancy day 18; and lanes 6 and 12, lactation day 1.
mammary epithelium using the Cre-loxP recombination
system. LoxP sites had been introduced into the promoter
and second intron of the mouse bcl-x gene (Rucker et al.,
2000) and transgenic mice had been generated that carry the
Cre gene under control of the MMTV-LTR and the
mammary-specific WAP gene promoter (Wagner et al.,
1997a). While the MMTV-Cre mice expressed Cre-recom-
binase in ductal epithelium of virgin mice and in alveolar
epithelium throughout pregnancy (Wagner et al., 2001), the
WAP-Cre gene was active in differentiating alveolar cells at
late pregnancy and lactation (Fig. 6A and data not shown).
We utilized these characteristics in expression kinetics to
delete the bcl-x gene in specific cell types and during differ-
ent developmental stages. Mice were generated that carried
two conditional bcl-x alleles ( fl/fl) and the MMTV-Cre ( fl/fl;
MC mice) or WAP-Cre ( fl/fl; WC mice) transgene. Deletion
of the bcl-x gene was evaluated on the level of DNA and
protein. To avoid potential problems with the preferential
death and therefore loss of Bcl-x-null cells, we performed
Southern blot analyses on mice that contained one wild type
and one conditional bcl-x allele ( fl/1) and the WAP-Cre
transgene ( fl/1; WC mice). The 6 kb fragment represented
the bcl-x null allele, whereas the 7 kb fragment indicated the
wild type and the non-recombined floxed alleles (Fig. 3A).
Since the Cre transgene was only active in mammary epithe-
lium and not in the stroma, the fragment containing the wild
type and floxed alleles was more intense (Fig. 3A). In
contrast, deletion of the bcl-x gene from hematopoietic
cells (Wagner et al., 2000) resulted in the selective ampli-
fication of Bcl-x null cells in spleen, and thus a complete
deletion was apparent (Fig. 3A). Western blot analyses
established the reduction of Bcl-x in mammary tissue of
bcl-x fl/fl; WC mice (Fig. 3B). Similarly, Bcl-x was absent
from Bcl-x null hematopoietic cells (Fig. 3B). Quality of
loading was monitored through Coomassie Blue staining
(Fig. 3B, lower panel). Loss of Bcl-x was also seen in
mice whose bcl-x alleles were conditionally deleted with
MMTV-Cre (Fig. 6B).
2.4. Bcl-x is not required for functional mammary gland
development
Bcl-x is the most abundant cell survival factor of the Bcl-
2 family (as assessed by RNase protection assays) during
pregnancy and the first phase of involution. To investigate
its role in mammopoiesis we monitored ductal and alveolar
development and function in mice from which the bcl-x
gene had been deleted using MMTV-Cre or WAP-Cre trans-
genes. In the absence of Bcl-x, mammary ducts exhibited
normal elongation and branching during puberty, and
alveoli formed and differentiated during pregnancy (data
not shown). Furthermore, Bcl-x-null mammary tissue was
fully functional and dams could support their litters (data
not shown). During lactation, the mammary fat pads of fl/fl;
WC (Fig. 4C) and fl/fl; MC (Fig. 5C) were filled with secre-
tory lobulo-alveolar structures. Even after several pregnan-
cies these mice were able to raise their litters (data not
shown).
2.5. Bcl-x promotes cell survival in the first stage of
involution
Bcl-x gene expression is highly induced in the first stage of
involution. We addressed the question as to whether the
presence of Bcl-x at the transition of lactation to involution
participates in the controlled death of mammary epithelium.
Pups were removed from fl/fl and fl/fl; WC dams at peak
lactation and the number of alveoli containing dead cells
and the numbers of shed cells were determined at 24 and
48 h of involution (Figs. 4 and 8A). No significant differences
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Fig. 2. Western blots of protein extracts from the mammary glands of
transplanted mice at lactation day 1 probed with anti-Bcl-x, anti-Stat5a,
anti-Stat5b, anti-SGP-2, anti-Stat3, and anti-Stat1 (p84-91). Lanes are wild
type cleared fat pad, wild type (sibling of Stat5-null) transplant, Stat5-null
transplant, wild type (sibling of PRLR-null) transplant, and PRLR-null
transplant.
were observed between fl/fl and fl/fl; WC mice at 24 h (Fig.
4B,D). In contrast, the number of alveoli with shed cells and
the number of shed cells per alveolus at 48 h was three-fold
greater in the Bcl-x-null tissue as compared to control tissue
(Figs. 4F,H and 8A,B). Similar increases were seen in the
Bcl-x null tissue deleted with MMTV-Cre as compared to the
control tissue (Figs. 5B,D and 8A,B). To determine the cells
from which the bcl-x gene had been deleted we generated fl/fl;
WC and fl/fl; MC mice that also carried the ROSA26 reporter
gene. After parturition, more than 80% of the alveolar cells
stained blue (Fig. 6A,B), suggesting that the majority of cells
had undergone Cre-mediated recombination. In addition, at
48 h after weaning most cells shed into the lumina stained
blue (data not shown). Deletion of the bcl-x gene using the
MMTV-Cre transgenic mice also resulted in increased cell
death at 48 h of involution (Fig. 5D). We further investigated
the integrity of mammary tissue after 5 days of involution and
did not observe a difference between fl/fl; WC and fl/fl mice
(data not shown).
We measured alveolar cell death using ApopTag assays
on tissue during pregnancy, at day 10 of lactation and 24 and
48 h of involution. No significant differences were observed
during pregnancy, at day 10 of lactation and 24 h of involu-
tion (data not shown). However, at 48 h of involution the
apoptotic rate was 4% in fl/fl mice, 10% in fl/fl; WC mice,
and 9% in fl/fl; MC mice (Fig. 8C).
2.6. Alveolar differentiation in the absence of Bcl-x
We investigated whether the loss of Bcl-x altered the
expression of genes that define alveolar differentiation and
apoptosis. Specifically, the expression of Stats 1, 3, and 5
and SGP-2 was analyzed during lactation and involution.
Bcl-x levels were sharply reduced in bcl-x fl/fl mice carrying
either the WAP-Cre (Fig. 7A) or the MMTV-Cre transgene
(Fig. 7B). As controls we used spleen from wild type and
bcl-x fl/fl; MC mice (Wagner et al., 2000). Bcl-x levels were
greatly reduced in the mutant spleens (Fig. 7A,B). In wild
type mice Stat5a and 5b levels were highest during lactation
and decreased during involution (Fig. 7). A similar pattern
was observed in fl/fl; WC mice (Fig. 7A). In contrast, the
decrease of Stat5 was more profound during involution in
bcl-x fl/fl; MC mice (Fig. 7B). The levels of Stat3, a protein
that has been linked to the initiation/progression of involu-
tion (Chapman et al., 1999), increased slightly during invo-
lution in wild type mice (Fig. 7). Increased Stat3 levels were
also observed in bcl-x fl/fl; WC mice (Fig. 7A), but not in fl/
fl; MC mice (Fig. 7B). The presence of a shorter form of
Stat3 in spleens from bcl-x fl/fl; MC mice may reflect the
altered cell type in these mice (Wagner et al., 2000). SGP-2
(Strange et al., 1992) is highly induced in mammary epithe-
lium from wild type mice during the early phase of involu-
tion (Fig. 7). A similar induction was observed during
involution of the bcl-x fl/fl mice in the presence of either
Cre transgene (Fig. 7). The expression profiles during lacta-
tion and involution were similar in fl/fl; WC mice that also
lacked the two bax alleles (data not shown).
3. Discussion
Bcl-x is the most abundant member of the Bcl-2 family of
proteins in a wide variety of cell types, including hemato-
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Fig. 3. DNA and protein analyses of mammary tissue from control and
conditionally deleted bcl-x mice. (A) Southern blot of genomic DNA
digested with EcoRI and probed for the bcl-x gene. Lanes are: spleen
DNA from a bcl-x fl/fl; MMTV-CreD mouse (Wagner et al., 2000) (note
that bcl-x null erythroid cells are preferentially amplified so that a complete
deletion was observed), and DNA from lactating mammary tissue of two
mice carrying the WAP-Cre transgene, one floxed bcl-x allele, and one wild
type bcl-x allele; the wild type and floxed alleles appear as the upper band
(7 kb) and the null allele as the lower band (6 kb). Note that the WAP gene
promoter targets Cre expression only to mammary epithelial cells, and that
the underlying stroma will carry only non-recombined bcl-x alleles. (B)
Western blot of total protein lysate using anti-Bcl-x antibodies (top
panel) with corresponding Coomassie Blue staining (bottom panel).
Lanes are: molecular marker ladder (seen in Comassie Blue staining
only), protein from the spleen of a mouse with two wild type bcl-x alleles,
protein from the spleen of a mouse with the MMTV-CreD transgene, and
two floxed bcl-x alleles (Wagner et al., 2000), mammary protein from a bcl-
x fl/fl mouse during lactation, mammary protein from a bcl-x fl/1; WAP-
Cre mouse during lactation, mammary protein from a bcl-x fl/fl; WAP-Cre
mouse during lactation. The nature of the lower molecular band seen in the
bcl-x fl/1; WC lane is not clear but it could represent Bcl-xS.
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Fig. 4. Accelerated apoptosis of mammary epithelial cells upon deletion of the bcl-x gene by WAP-Cre. Mammary tissue from bcl-x fl/fl (panels A, B, E, F) and
bcl-x fl/fl; WC (panels C, D, G, H) mice day 10 of lactation (panels A, C, E, G), 24 h of involution (panels B, D), and 48 h of involution (panels F, H). (A)
Lactating (L10) fourth mammary gland from a fl/fl mouse. (B) Opposite side fourth mammary gland taken from the same mouse at 24 h of involution. (C)
Lactating fourth mammary gland from a bcl-x fl/fl; WC mouse. (D) Opposite side fourth mammary gland taken from the same mouse as (C) at 24 h of
involution. (E) Lactating (L10) fourth mammary gland from a fl/fl mouse. (F) Opposite side fourth mammary gland taken from the same mouse as in (E) at 2
days of involution. (G) Lactating fourth mammary gland from a bcl-x fl/fl; WC mouse. (H) Opposite side fourth mammary gland taken from the same mouse as
(G) at 2 days of involution. Panels A–H, 100 £ magnification.
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Fig. 6. LacZ and ApopTag staining of control and bcl-x conditionally deleted mammary glands. (A) LacZ stained mammary tissue from a bcl-x fl/fl; WC;
ROSA26 mouse at day 10 of lactation. (B) LacZ stained mammary tissue from a bcl-x fl/1; MC; ROSA26 mouse at day 10 of lactation. (C, D) ApopTag staining
of bcl-x fl/fl (C) and bcl-x fl/fl; WC (D) mammary tissue at 48 h of involution. Panels A–G, 630 £ magnification.
Fig. 5. Accelerated apoptosis of mammary epithelial cells upon deletion of the bcl-x gene by MMTV-CreD. Mammary tissue from bcl-x fl/1 (panels A, B) and
bcl-x fl/fl; MC mice (panels C, D) at day 10 of lactation (panels A, C), and at 48 h of involution (panels B, D). (A) Lactating mammary gland from a fourth
mammary gland from a fl/1 mouse. (B) Opposite side fourth mammary gland taken from the same fl/1 mouse at 48 h of involution. (C) Lactating fourth
mammary gland from a bcl-x fl/fl; MC mouse. (D) Opposite side fourth mammary gland taken from the same mouse as (C) at 48 h of involution. Magnification
for A–D is 100 £ .
poietic cells, germ cells and mammary epithelial cells. Its
vital role in mouse development and physiology has been
confirmed through gene inactivation experiments
(Motoyama et al., 1995; Rucker et al., 2000; Shindler et
al., 1997; Wagner et al., 2000). Based on our work and
that of others it is now clear that the physiological role of
Bcl-x in promoting cell survival is not only dependent on
the cell type, but also linked to defined developmental
stages. Here we show that the physiological role of Bcl-x
in mammary epithelium is confined to the first stage of
involution, a phase characterized by increased apoptosis.
Although Bcl-x is the most abundant cell survival factor
throughout pregnancy and lactation, its presence is not
required for the development and function of mammary
epithelial cells. At this point it is not clear whether any of
the Bcl-2 survival factors are critical by themselves during
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Fig. 7. Western blot analyses of differentiation and death markers upon deletion of the bcl-x gene using WAP-Cre (A) and MMTV-Cre (B) transgenic mice.
Western blots of mammary tissue were probed for Bcl-x, Stat5a, Stat5b, SGP-2, Stat3, and Stat1. Spleen extract from wild type and fl/fl; MC mice was
described earlier (Wagner et al., 2000). L, mammary tissue from mice at day 10 of lactation; I, mammary tissue from mice at 48 h of involution.
pregnancy and lactation. No mammary phenotype has been
reported in Bcl-w-null (Print et al., 1998) and Bcl-2-null
mice (Veis et al., 1993). Overexpression of Bcl-2 in
mammary epithelium results in increased proliferation
within the terminal end bud (Humphreys et al., 1996) and
increased resistance to apoptosis (Schorr et al., 1999). It has
been suggested that members of the Bcl-2 family promote
cell survival during pregnancy and that a shift towards cell
death factors induces apoptosis during involution (Metcalfe
et al., 1999). These investigators hypothesized that the
decline of Bcl-w during involution is a key initiating
event of cell death. We now show that Bcl-x constitutes a
mandatory cell survival signal after weaning and its loss
results in an accelerated epithelial cell death. Thus, the
presence of Bcl-w by itself cannot maintain cell survival.
The physiological role of Bcl-x in the first phase of
mammary involution is subject to speculation. It is clear
that the absence of Bcl-x does not adversely affect develop-
ment and function of the gland, and that accelerated involu-
tion does not interfere with the gland’s ability to function
after subsequent pregnancies. It is possible that the presence
of Bcl-x prevents premature involution of a gland under
more natural conditions. In addition to the survival role
that Bcl-x plays in involution, it also seems to have an effect
on the survival of transformed cells and tumor cells. Ectopic
overexpression of Bcl-x or Stat5-mediated activation of the
bcl-x gene exists in transformed cell types and may contri-
bute to the survival properties of tumor cells. For example,
in lymphoid cells Bcr/Abl can induce bcl-x gene expression
through the activation of Stat5 (Gesbert and Griffin, 2000;
Horita et al., 2000). In addition, overexpression of Bcl-x can
promote chemotherapy resistance of mammary tumors in a
syngeneic mouse model (Liu et al., 1999) and malignant
conversion of skin papillomas (Pena et al., 1998).
Activation of bcl-x and bax gene expression is rapidly
induced upon weaning, and gamma interferon activated
sequence (GAS) sites (binding sites for Stat proteins) have
been identified in the promoter and body of the bcl-x gene.
The induction of bcl-x gene expression during pregnancy and
involution can be correlated with the activation of Stat5 and
Stat3, respectively. However, no reduction of Bcl-x levels
were observed in mammary tissue isolated from Stat5-null
mice (this study) or mammary-specific Stat3 null mice
(Chapman et al., 1999). Although there are reports based
on tissue culture cells and gene knockout mice (Socolovsky
et al., 1999) that Stat5 can induce transcription of the bcl-x
gene in erythroid cells through direct binding to GAS sites in
the promoter of the bcl-x gene, our data demonstrate that this
is not the case in mammary epithelium. Clearly, bcl-x gene
expression is independent of the prolactin receptor and Stat5.
We have also demonstrated that bcl-x gene expression is
independent of Stat5 in the ovary (unpublished). It is possible
that activation of the bcl-x gene in mammary epithelium is
controlled by glucocorticoids (Schorr and Furth, 2000).
While it is generally recognized that members of the Bcl-
2 family can control the balance between cell survival and
death (Vaux and Korsmeyer, 1999), research from our
laboratory and that of others also point to an underlying
cell- and developmental-specificity (Table 1). Cells from
the erythroid, mammary, neuronal, and ovarian compart-
ments exemplify the cell- and stage-specificity of Bcl-x
function. While Bcl-x is mandatory for the survival of
mature erythrocytes, it is dispensable for immature erythro-
cytes (Wagner et al., 2000). Bcl-x is also required for the
survival of primordial germ cells (Rucker et al., 2000), but is
not necessary in follicles and mature oocytes (unpublished).
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Fig. 8. Number of mammary alveoli during involution that contain shed
(apoptotic) cells (A), number of shed cells per alveolus (B), percent of
ApopTag positive alveolar cells (C). Three fl/fl and three fl/fl; WC litter-
mates were analyzed, and three fl/fl and three fl/fl; MC littermates were
analyzed. The hatched bar represents fl/fl mice, the solid gray bar represents
the fl/fl; WC mice, the spotted bar represents fl/fl mice, and the solid white
bar represents fl/fl; MC mice. Details of counting are in Section 4.4.
It has been shown in vitro that Bcl-x and Bax constitute a
rheostat that controls cell survival and death (reviewed in
Vaux and Korsmeyer, 1999). In vivo data now suggest that
the presence of such a rheostat is cell-specific (Rucker et al.,
2000; Wagner et al., 2000) (Table 1). To investigate whether
the loss of Bax could rescue the accelerated apoptosis seen
in bcl-x fl/fl; WC mice, we generated fl/fl; WC mice that were
also null for the bax gene. Pregnancy-induced mammopoi-
esis appeared normal and these mice were able to nurse their
pups (unpublished). Involution of mammary tissue in these
mice was similar to that seen in the presence of Bax (unpub-
lished). Despite extensive efforts, we were unable to obtain
the expected number of fl/fl; MMTV-Cre; bax null mice (one
out of 37). Since the MMTV-LTR is expressed in many cell
types, it is possible that the combined deletion of Bcl-x and
Bax resulted in embryonic death. Similar to the mammary
gland, erythrocytes from which both Bcl-x and Bax were
absent still exhibited a Bcl-x null phenotype (loss of mature
erythrocytes) (Wagner et al., 2000). In contrast, the deletion
of the bax gene from Bcl-x hypomorphic mice resulted in
the rescue of the defect (restoration of germ cells) (Rucker
et al., 2000). Likewise, the loss of immature neurons in the
developing central nervous system (CNS) in the absence of
Bcl-x was partially reversed upon the deletion of the bax
gene (Shindler et al., 1997). Thus Bcl-x and Bax constitute a
critical survival–death balance in specific cell types during
defined developmental periods.
4. Experimental procedures
4.1. Transgenic mice
Conditional bcl-x mice had been generated by inserting
loxP sites into the upstream region of the bcl-x gene and into
the second intron (Rucker et al., 2000). These mice were
mated with WAP-Cre and MMTV-Cre transgenic mice
(Wagner et al., 1997a) and with ROSA26 reporter mice
(Soriano, 1999). The mice were of mixed background
(129 and C57/B6).
The genotype of the mice was determined by PCR
analyses. Primers for the bcl-x gene were 5 0-CTG-CTC-
GCC-ACC-TCA-TCA-GTC-3 0 and 5 0-GTC-TCA-GAA-
GCC-GCA-ATA-TCC-3 0 which yielded a 175 base pair
(bp) product from the floxed allele and a 135 bp product
from the wild type allele after 30 cycles at 658C annealing.
Primers for the Cre transgenes were 5 0-TAG-AGC-TGT-
GCC-AGC-CTC-TTC-C-3 0 which binds in the WAP gene
promoter, 5 0-GGT-TCT-GAT-CTG-AGC-TCT-GAG-TG-
3 0 which binds in the MMTV-LTR, and 5 0-CAT-CAC-
TCG-TTG-CAT-CGA-CCG-G-3 0 which binds in the Cre
sequence. Using the respective promoter primers with the
Cre primer, the WAP-Cre transgene produced a 240 bp frag-
ment and the MMTV-Cre transgene produced a 280 bp frag-
ment after 30 cycles at 658C annealing. The ROSA26
transgene produced a 425 bp product with primers 5 0-
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Table 1
Contributions of Bcl-x and Bax in mouse development
Genotype Mammary gland Erythroid Germ cells Neurons
Conditional bcl-x
deletion (mouse)
Normal development Severe hemolytic anemia Loss of primordial germ cells Not determined
Loss of resistance to
apoptosis
Hyperplasia of immature
erythroid cellsa
Males are sterile, females
have decreased fertilityb
bcl-x null (mouse and ES
cell)
Lethal by E12.5 Lack adult definitive
erythrocytesc
Lethal by E12.5 Increased apoptosis in the
brain stem and spinal cordc
Not determined Not determined
bax null (mouse) Reduced apoptosis only
during first stage of
involutiond
Normal erythroid
developmente
Higher ovarian reservef Increased number and
survival of various types of
neuronsh
Males sterile, accumulate
premeiotic germ cellse,g
bcl-x null and bax null
(mouse or cell line)
Normal development Same phenotype as tissue
specific bcl-x deletion,
function not restoreda
Functional germ cells, loss of
bax prevents bcl-x deletion
phenotypeb
Greatly reduced levels of
apoptosis in vivo and in vitro
when compared to mice
lacking just bcl-xg
Loss of resistance to
apoptosis alleviated
a (Wagner et al., 2000).
b (Rucker et al., 2000).
c (Motoyama et al., 1995).
d (Schorr et al., 1999).
e (Knudson et al., 1995).
f (Perez et al., 1999).
h (Deckwerth et al., 1996).
g (Shindler et al., 1997).
GAT-CCG-CGC-TGG-CTA-CCG-GC-3 0 and 5 0-GGA-
TAC-TGA-CGA-AAC-GCC-TGC-C-3 0 annealing at 658C
for 30 cycles. All products were separated in 2.5% agarose
TAE gels.
For all mice studied, the right side fourth mammary gland
was biopsied after lactating for 7–10 days. The pups were
removed at the time of the biopsy, and the left side fourth
mammary gland was harvested at 24 h, 2-, 3-, or 4 days
post-weaning. Lymph nodes were also surgically excised
at the time of mammary gland biopsies. More than 30 fl/fl;
WAP-Cre mice and more than 30 control littermates, more
than 20 fl/fl; MMTV-Cre mice and more than 20 control
littermates, and five fl/fl; WAP-Cre; bax-null and 15 control
littermates were analyzed. Only one out of 37 mice geno-
typed was fl/fl; MMTV-Cre; bax-null (20 of these mice were
from matings of fl/fl; MMTV-Cre; bax 1/2).
Stat5a-null (Liu et al., 1997), Stat5-null (lack both Stat5a
and 5b) (Teglund et al., 1998) and PrlR-null (Teglund et al.,
1998) mice were used to examine if bcl-x transcription is
under the control of the Prl/Jak2/Stat5 pathway. Protein
from virgin mammary tissue was analyzed. Since Stat5-
null and PrlR-null mice are infertile, we transplanted
mammary epithelium (Robinson et al., 1998) from these
mice into wild type hosts and analyzed the tissue after one
pregnancy.
4.2. Southern analysis
Genomic DNA was isolated from mammary gland tissue
by digesting in a solution consisting of Proteinase K (20 ng/
ml) in 1% sodium dodecyl sulphate (SDS), 50 mM Tris–HCl
at pH 8.0, 20 mM NaCl, and 1 mM ethylenediaminetetra-
acetic acid (EDTA), extracted with phenol/chloroform,
precipitated in isopropanol, air-dried, and resuspended in
TE. Genomic DNA (30 mg) was cut with EcoRI and sepa-
rated in a 0.7% TAE gel, blotted onto a nylon membrane and
hybridized with the 32P-labeled probe (described below) for
4 h at 658C with QuikHyb (Stratagene) and sheared salmon
sperm DNA. Membranes were washed with 2 £ SSC, 0.1%
SDS for 20 min and then twice with 2 £ SSC, 0.01% SDS
for 20 min, and exposed on autoradiography film.
Template DNA to be used as a probe in the Southern
analysis was PCR amplified from C57BL/6 mouse genomic
DNA using the following primers: 5 0-TAG-TAG-CTG-
TCG-TGG-TAG-GCG-3 0 and 5 0-GTT-CAT-TTA-CAG-
ATT-AGC-TTT-CAA-G-3 0, which bind in exon 2 of the
bcl-x gene. The PCR product was run in a 1% TAE gel
and purified using a gel extraction kit (Qiagen). Two
hundred nanogram of template was used to transcribe the
probe with the Stratagene PrimeIt II kit with 32P-radiola-
beled dCTP. Probes were purified through G-50 Sephadex
columns and their incorporation of radioactivity was deter-
mined by Cherenkov counting. The probe was denatured
and hybridized to the DNA on the membrane as described
above.
4.3. Western analysis
Protein was extracted from various tissues by homogeni-
zation in lysis buffer (0.04 M Tris–HCl, 0.28 M NaCl, 20%
(v/v) glycerol, 2%(v/v) NP-40, 4 mM EDTA, 20 mM NaF
with the addition of 100 ml of 10 mg/ml PMSF, 40 ml of
10 mg/ml aprotinin, 40 ml of 10 mg/ml of leupeptin, and
200 ml of 0.1 M Na-vanadate to each 10 ml) and rotated
for 1 h at 48C. Protein concentration was determined by
bicinchoninic acid (BCA) colorimetric detection kit
(Pierce). Sixty micrograms of lysate were run in a 14%
Tris–glycine SDS gel to separate the proteins. Blocking
was performed for 2 h at room temperature in 3%(w/v)
dried non-fat milk in 1 £ TBST. Primary antibodies were
diluted in 3% dried non-fat milk in 1 £ TBST and incubated
with the membrane at room temperature for 1–2 h. Primary
antibodies tested were: anti-Bcl-x (Santa Cruz, sc-634)
diluted 1:500, anti-Stat5a antibody (Liu et al., 1997)
(1:20,000 dilution), anti-Stat5b (Liu et al., 1997)
(1:10,000 dilution), anti-SGP-2 (Santa Cruz sc-6420)
diluted 1:500, anti-Stat3 (Santa Cruz, sc-7179) diluted
1:1000, and anti-Stat1 (Santa Cruz, sc-346) diluted
1:1000. Secondary antibody, rabbit IgG-HRP, was diluted
1:5000 and incubated in 3%(w/v) milk in 1 £ TBST for 1 h
at room temperature. Excitation of the HRP was performed
with the Super Signal kit from Pierce for 5 min. ECL films
were exposed for 30 s, 1, 5, and 10 min.
4.4. Histology
Tissues were fixed in 2% paraformaldehyde for 2 h and
stained for b-galactosidase followed by a 1 h post-fix in
formaldehyde. Alternatively, they were kept for 4 h in Tell-
yesniczky’s fixative. Following fixation, tissues were dehy-
drated, paraffin embedded, and sectioned at 5 mm. Sections
were stained with hematoxylin and eosin, or with nuclear
fast red if they had been stained for b-galactosidase. For the
b-galactosidase assay samples were pre-stained in 2 mM
MgCl2, 0.01%(w/v) Na-deoxycholate, and 0.02%(w/v)
Igepal (NP-40) in 1 £ PBS. Following pre-stain, the samples
were stained in 30 mM (K4Fe(CN)6, 30 mM K3Fe(CN),
2 mM MgCl2, 0.01%(w/v) Na-deoxycholate, and 0.02%(v/
v) NP-40 in 1 £ PBS with 1 mg/ml of X-gal. Samples were
washed in 1 £ PBS, dehydrated through alcohol, post-fixed
for 1 h in formaldehyde, and processed as described above.
A detailed description of the b-galactosidase staining can be
found at http://mammary.nih.gov/tools/histological/Histol-
ogy/index.html#a2. Counting of histological sections was
performed on three mice of each genotype ( fl/fl, fl/fl; WC,
fl/fl, fl/fl; MC).
The number of alveoli with shed cells was determined for
each sample by counting the alveoli with shed cells as a
percentage of the total alveoli. The numbers counted
were: 661/2064 (32%), 195/691 (28.2%), 579/1874
(30.9%) for fl/fl mice, 2213/2437 (90.8%), 2485/2628
(94.6%), 2648/2905 (91.2%) for fl/fl; WC mice, 185/528
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(35%), 241/850 (28.4%), 754/1488 (50.6%) for fl/fl mice,
and 805/885 (90.9%), 432/474 (91.1%), 799/930 (85.9%)
for fl/fl; MC mice. These numbers gave averages of
30.37% ðSD ¼ 1:9553Þ, 92.2% ðSD ¼ 2:0881Þ, 38%
ðSD ¼ 11:4000Þ, and 89.3% ðSD ¼ 2:93Þ, respectively.
The P value for the t-test of fl/fl versus fl/fl; WC mice was
0.00141, and for fl/fl versus fl/fl; MC mice the P value was
0.02474.
The number of shed cells per alveolus was determined for
each sample by counting the number of shed cells and the
number of alveoli and calculating the average. The numbers
counted were: 229/499 (2.26), 134/353 (2.63), 143/321
(2.24) for fl/fl mice, 155/1070 (6.9), 159/1160 (7.3), 160/
1304 (8.15) for fl/fl; WC mice, 406/882 (2.17), 855/2177
(2.55), 975/3182 (3.26) for fl/fl mice, 550/3157 (5.74),
492/2800 (5.69), 532/3452 (6.49) for fl/fl; MC mice. These
numbers gave averages of 2.373 ðSD ¼ 0:2223Þ, 7.45
ðSD ¼ 0:6384Þ, 2.6567 ðSD ¼ 0:5543Þ, and 5.9733
ðSD ¼ 0:4392Þ, respectively. The P value for the t-test of
fl/fl; WC mice was 0.0002, and for fl/fl versus fl/fl; MC mice
the P value was 0.0015.
4.5. ApopTag assay
Tissues were agitated in Tellyesniczky’s fixative for 4 h
and then dehydrated, paraffin embedded, and sectioned at
5 mm. ApopTag assay was performed using the Intergen
ApopTag In Situ Apoptosis Detection Kit. Methyl green
(0.01%) was used for counter staining. Counting of Apop-
Tag positive cells was performed at 200 £ magnification
and then confirmed by morphological appearance at
630 £ . The numbers counted were: 25/554 (4.5), 26/617
(4.2), 26/639 (4.1) for fl/fl mice, 67/578 (11.6), 58/543
(10.7), 51/555 (9.2) for fl/fl; WC mice, 30/750 (4), 37/651
(5.7), 37/831 (4.4) for fl/fl mice, 47/506 (9.3), 56/531 (10.5),
41/534 (7.7) for fl/fl; MC mice. These numbers gave
averages of 4.25 ðSD ¼ 0:2248Þ, 10.46 ðSD ¼ 1:2644Þ,
4.667 ðSD ¼ 0:8327Þ, and 9.1667 ðSD ¼ 1:405Þ, respec-
tively. The P value for the t-test of fl/fl; WC mice was
0.0095, and for fl/fl versus fl/fl; MC mice the P value was
0.0078.
4.6. RNA analysis
Total RNA was isolated from tissue samples using the
guanidinium thiocyanate method (Chomczynski and Sacchi,
1987). All RNA samples were pooled from three or more
mice. The mouse Apo-2 template set (Pharmingen; consists
of templates for bcl-w, bfl1, bcl-x, bak, bax, bcl-2, bad, L32,
GAPDH) was labeled with a 32P-labeled UTP according to
the Riboquant Multi-Probe RNase Protection Assay System
Instruction Manual. Total RNA (7 mg)were hybridized with
2.4 £ 105 cpm/ml of the Apo-2 labeled templates according
to the manufacturer’s specifications. Following RNase treat-
ment and chloroform:isoamyl alcohol extraction, the
protected products were run in a NOVEX QuickPoint precast
sequencing gel and exposed on autoradiography film.
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